BeiGene Net Worth

BeiGene Net Worth Breakdown

  BGNE
The net worth of BeiGene is the difference between its total assets and liabilities. BeiGene's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of BeiGene's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. BeiGene's net worth can be used as a measure of its financial health and stability which can help investors to decide if BeiGene is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in BeiGene stock.

BeiGene Net Worth Analysis

BeiGene's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including BeiGene's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of BeiGene's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform BeiGene's net worth analysis. One common approach is to calculate BeiGene's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares BeiGene's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing BeiGene's net worth. This approach calculates the present value of BeiGene's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of BeiGene's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate BeiGene's net worth. This involves comparing BeiGene's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into BeiGene's net worth relative to its peers.

Enterprise Value

17.4 Billion

To determine if BeiGene is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BeiGene's net worth research are outlined below:
BeiGene had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 2.46 B. Net Loss for the year was (881.71 M) with loss before overhead, payroll, taxes, and interest of (511.06 M).
BeiGene currently holds about 5.7 B in cash with (1.16 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 55.17.
BeiGene has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company shares are held by company insiders
Latest headline from businesswire.com: BeiGene Demonstrates Global Progress in 2023 Responsible Business Sustainability Report
BeiGene uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in BeiGene. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to BeiGene's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know BeiGene's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as BeiGene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BeiGene backward and forwards among themselves. BeiGene's institutional investor refers to the entity that pools money to purchase BeiGene's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Amvescap Plc.2023-12-31
475.9 K
Goldman Sachs Group Inc2023-12-31
428.7 K
Artal Group S A2023-12-31
404.5 K
Public Investment Fund2023-12-31
354.4 K
First Trust Advisors L.p.2023-12-31
219.7 K
Bank Of America Corp2023-12-31
176.4 K
Capital International Sarl2023-12-31
176.3 K
M&g Investment Management Ltd2023-12-31
173.3 K
Baird Financial Group, Inc.2023-12-31
164.9 K
Baker Bros Advisors Lp2023-12-31
10.6 M
Capital Research & Mgmt Co - Division 32023-12-31
6.3 M
Note, although BeiGene's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow BeiGene's market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 16.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BeiGene's market, we take the total number of its shares issued and multiply it by BeiGene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

19.77 Billion

Project BeiGene's profitablity

BeiGene's profitability indicators refer to fundamental financial ratios that showcase BeiGene's ability to generate income relative to its revenue or operating costs. If, let's say, BeiGene is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BeiGene's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BeiGene's profitability requires more research than a typical breakdown of BeiGene's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.15)(0.16)
Return On Capital Employed(0.30)(0.32)
Return On Assets(0.15)(0.16)
Return On Equity(0.25)(0.26)
The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.61.
When accessing BeiGene's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures BeiGene's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BeiGene's profitability and make more informed investment decisions.
The data published in BeiGene's official financial statements usually reflect BeiGene's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BeiGene. For example, before you start analyzing numbers published by BeiGene accountants, it's critical to develop an understanding of what BeiGene's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of BeiGene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BeiGene's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BeiGene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BeiGene. Please utilize our Beneish M Score to check the likelihood of BeiGene's management manipulating its earnings.

Evaluate BeiGene's management efficiency

BeiGene has return on total asset (ROA) of (0.124) % which means that it has lost $0.124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2226) %, meaning that it created substantial loss on money invested by shareholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. As of May 1, 2024, Return On Tangible Assets is expected to decline to -0.16. In addition to that, Return On Capital Employed is expected to decline to -0.32. At present, BeiGene's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 215.8 M, whereas Non Currrent Assets Other are projected to grow to (17.8 M).
Last ReportedProjected for Next Year
Book Value Per Share 33.89  18.79 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 33.17  21.96 
Enterprise Value Over EBITDA(14.80)(15.54)
Price Book Value Ratio 5.32  4.02 
Enterprise Value Multiple(14.80)(15.54)
Price Fair Value 5.32  4.02 
Enterprise Value16.6 B17.4 B
The analysis of BeiGene's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze BeiGene's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of BeiGene Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue
5.4256
Revenue
2.5 B
Quarterly Revenue Growth
0.669
Revenue Per Share
23.554
Return On Equity
(0.22)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BeiGene insiders, such as employees or executives, is commonly permitted as long as it does not rely on BeiGene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BeiGene insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BeiGene Corporate Filings

8K
26th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
15th of April 2024
Other Reports
ViewVerify
F4
11th of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
26th of March 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
BeiGene time-series forecasting models is one of many BeiGene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BeiGene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

BeiGene Earnings per Share Projection vs Actual

Be your own money manager

Our tools can tell you how much better you can do entering a position in BeiGene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

BeiGene Corporate Directors

BeiGene corporate directors refer to members of a BeiGene board of directors. The board of directors generally takes responsibility for the BeiGene's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BeiGene's board members must vote for the resolution. The BeiGene board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Thomas MalleyNon-Executive Independent DirectorProfile
Qingqing YiDirectorProfile
Timothy ChenDirectorProfile
Ke TangDirectorProfile

How to buy BeiGene Stock?

The net worth of BeiGene is the difference between its total assets and liabilities. BeiGene's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of BeiGene's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. BeiGene's net worth can be used as a measure of its financial health and stability which can help investors to decide if BeiGene is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in BeiGene stock.

Already Invested in BeiGene?

The danger of trading BeiGene is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BeiGene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BeiGene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BeiGene is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.45)
Revenue Per Share
23.554
Quarterly Revenue Growth
0.669
Return On Assets
(0.12)
Return On Equity
(0.22)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.